Trial Profile
Fluvastatin +/- ezetimibe in patients with primary hypercholesterolaemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2012
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Fluvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions; Therapeutic Use
- 16 Nov 2012 New trial record
- 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.